{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:45:57Z","timestamp":1764510357652},"publisher-location":"Totowa, NJ","reference-count":23,"publisher":"Humana Press","isbn-type":[{"type":"print","value":"9781934115923"},{"type":"electronic","value":"9781597455541"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-59745-554-1_22","type":"book-chapter","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T19:09:03Z","timestamp":1235761743000},"page":"425-443","source":"Crossref","is-referenced-by-count":7,"title":["Anti-CD22 Onconase: Preparation and Characterization"],"prefix":"10.1007","author":[{"given":"Dianne L.","family":"Newton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke H.","family":"Stockwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna M.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G. Kohler","year":"1975","unstructured":"Kohler, G., and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495\u2013497.","journal-title":"Nature"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri1837","volume":"6","author":"P. J. Carter","year":"2006","unstructured":"Carter, P. J. (2006) Potent antibody therapeutics by design. Nature Rev. Immunol. 6, 343\u2013357.","journal-title":"Nature Rev. Immunol."},{"issue":"1","key":"22_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/bc010021y","volume":"13","author":"P. R. Hamann","year":"2002","unstructured":"Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., et al. (2002) Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody\u2013calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug. Chem. 13 (1), 47\u201358.","journal-title":"Bioconjug. Chem."},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.med.58.070605.115320","volume":"58","author":"I. Pastan","year":"2007","unstructured":"Pastan, I., Hassan, R., Fitzgerald, D. J., and Kreitman, R. J. (2007) Immunotoxin treatment of cancer. Annu. Rev. Med. 58, 221\u2013237.","journal-title":"Annu. Rev. Med."},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.seminoncol.2005.08.002","volume":"32","author":"L. Wong","year":"2005","unstructured":"Wong, L., Suh, D. Y., and Frankel, A. E. (2005) Toxin conjugate therapy of cancer. Semin. Oncol. 32, 591\u2013595.","journal-title":"Semin. Oncol."},{"key":"22_CR6","volume-title":"Handbook of Therapeutic Antibodies","author":"S. M. Rybak","year":"2007","unstructured":"Rybak, S. M., and Newton, D. L. (2007) Immunotoxins and beyond: Targeted RNases. In: Dubel, S. (ed). Handbook of Therapeutic Antibodies, Wiley-VCH, Weinheim."},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"21202","DOI":"10.1016\/S0021-9258(18)54841-9","volume":"266","author":"S. M. Rybak","year":"1991","unstructured":"Rybak, S. M., Saxena, S. K., Ackerman, E. J., and Youle, R. J. (1991) Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins. J. Biol. Chem. 266, 21202\u201321207.","journal-title":"J. Biol. Chem."},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10717549309031335","volume":"1","author":"S. M. Rybak","year":"1993","unstructured":"Rybak, S. M., Newton, D. L., Mikulski, S. M., Viera, A., and Youle, R. J. (1993) Cytotoxic Onconase and ribonuclease A chimeras: Comparison and in vitro characterization. Drug Delivery 1, 3\u201310.","journal-title":"Drug Delivery"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"19572","DOI":"10.1016\/S0021-9258(18)41813-3","volume":"267","author":"D. L. Newton","year":"1992","unstructured":"Newton, D. L., Ilercil, O., Laske, D. W., Oldfield, E., Rybak, S. M., and Youle, R. J. (1992) Cytotoxic ribonuclease chimeras: Targeted tumoricidal activity in vitro and in vivo. J. Biol. Chem. 267, 19572\u201319578.","journal-title":"J. Biol. Chem."},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0960-9822(00)00220-7","volume":"4","author":"S. Kelm","year":"1994","unstructured":"Kelm, S., Pelz, A., Schauer, R., Filbin, M. T., Tang, S., deBellard, M.-E., et al. (1994) Sialoadhesin, myelin-associate glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4, 965\u2013972.","journal-title":"Curr. Biol."},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1200\/JCO.2005.11.437","volume":"23","author":"R. J. Kreitman","year":"2005","unstructured":"Kreitman, R. J., Squires, D. R., Stetler-Stevenson, M., Noel, P., fitzGerald, D. J. P., Wilson, W. H., et al. (2005) Phase I trial of recombinant immunotoxin RFB4(dsFv)-PAE38 (BL22) in patients with B-cell malignancies. J. Clin. Onc. 23, 6719\u20136729.","journal-title":"J. Clin. Onc."},{"key":"22_CR12","first-page":"169","volume":"21","author":"Z. Darzynkiewicz","year":"1988","unstructured":"Darzynkiewicz, Z., Carter, S. P., Mikulski, S. M., Ardelt, W. J., and Shogen, K. (1988) Cytostatic and cytotoxic effects of Pannon (P-30 protein) a novel anti-cancer agent. Cell Tissue Kinet. 21, 169\u2013182.","journal-title":"Cell Tissue Kinet."},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jnci\/82.2.151-a","volume":"82","author":"S. M. Mikulski","year":"1990","unstructured":"Mikulski, S. M., Ardelt, W., Shogen, K., Bernstein, E. H., and Menduke, H. (1990) Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos. J. Natl. Cancer Inst. 82, 151\u2013153.","journal-title":"J. Natl. Cancer Inst."},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/bbrc.1994.2439","volume":"204","author":"J. J. Lin","year":"1994","unstructured":"Lin, J. J., Newton, D. L., Mikulski, S. M., Kung, H. F., Youle, R. J., and Rybak, S. M. (1994) Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease. Biochem. Biophys. Res. Commun. 204, 156\u2013162.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"22_CR15","first-page":"1983","volume":"60","author":"M. S. Iordanov","year":"2000","unstructured":"Iordanov, M. S., Ryabinina, O. P., Wong, J., Dinh, T.-H., Newton, D. L., Rybak, S. M., et al. (2000) Molecular determinants of programmed cell death induced by the cytotoxic ribonuclease Onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis. Cancer Res. 60, 1983\u20131994.","journal-title":"Cancer Res."},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"15142","DOI":"10.1074\/jbc.M108115200","volume":"277","author":"S. Saxena","year":"2002","unstructured":"Saxena, S., Sirdeshmukh, R., Ardelt, W., Mikulski, S. M., Shogen, k., and Youle, R. J. (2002) Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family. J. Biol. Chem. 277, 15142\u201315146.","journal-title":"J. Biol. Chem."},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/07357900500283143","volume":"23","author":"J. Costanzi","year":"2005","unstructured":"Costanzi, J., Sidransky, D., Navon, A., and Goldsweig, H. (2005) Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase. Cancer Invest. 23, 643\u2013650.","journal-title":"Cancer Invest."},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4161\/cc.2.1.232","volume":"2","author":"B. Ardelt","year":"2003","unstructured":"Ardelt, B., Ardelt, W., and Darzynkiewicz, Z. (2003) Cytotoxic ribonucleases and RNA interference (RNAi). Cell Cycle 2, 22\u201324.","journal-title":"Cell Cycle"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO.20.1.274","volume":"20","author":"S. Mikulski","year":"2002","unstructured":"Mikulski, S., Costanzi, J., Vogelzang, N., McCachres, S., Taub, R., Chun, H., et al. (2002) Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma. J. Clin. Oncol. 20, 274\u2013281.","journal-title":"J. Clin. Oncol."},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9258(18)52427-3","volume":"266","author":"W. Ardelt","year":"1991","unstructured":"Ardelt, W., Mikulski, S. M., and Shogen, K. (1991) Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. J. Biol. Chem. 266, 245\u2013251.","journal-title":"J. Biol. Chem."},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1523\/JNEUROSCI.14-02-00538.1994","volume":"14","author":"D. L. Newton","year":"1994","unstructured":"Newton, D. L., Walbridge, S., Mikulski, S. M., Ardelt, W., Shogen, K., Ackerman, S. J., et al. (1994) Toxicity of an anti-tumor ribonuclease to Purkinje neurons. J. Neurosci. 14, 538\u2013544.","journal-title":"J. Neurosci."},{"key":"22_CR22","first-page":"1302","volume":"6","author":"R. A. Messmann","year":"2000","unstructured":"Messmann, R. A., Vitetta, E. S., Headlee, D., Senderowicz, A. M., Figg, W. D., Schindler, J., et al. (2000) A phase 1 study of combination therapy with immunotoxins IgG-HD37-deglycosylated Ricin A chain (dgA) and IgG-RFB4-dgA (combotox) in patients with refractory CD19 (+), CD22 (\u2013) B cell lymphoma. Clin. Cancer Res. 6, 1302\u20131313.","journal-title":"Clin. Cancer Res."},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ijc.2910450318","volume":"45","author":"M. A. Ghetie","year":"1990","unstructured":"Ghetie, M. A., Richardson, J., Tucker, T., Jones, D., Uhr, J. W., and Vitetta, E. S. (1990) Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int. J. Cancer 45, 481\u2013485.","journal-title":"Int. J. Cancer"}],"container-title":["Methods in Molecular Biology\u2122","Therapeutic Antibodies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-59745-554-1_22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T12:55:29Z","timestamp":1633179329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-59745-554-1_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,10]]},"ISBN":["9781934115923","9781597455541"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-59745-554-1_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2008,12,10]]}}}